Epithelial Ovarian Cancer
📧 Sign up to get email alerts when something new happens for Epithelial Ovarian Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2025-06-08Clinical Trial Update: Biomarker-driven Targeted Therapy in Patients With Recurrent Platinum-resistant Epithelial Ovarian Cancer [Phase 2]
Phase 2 trial evaluating a biomarker-driven targeted therapy for recurrent platinum-resistant epithelial ovarian cancer has completed.
-
CLINICAL_TRIALS trial_result · 2025-06-08Clinical Trial Update: A Study to Evaluate the Safety of KAND567, in Combination With Carboplatin Therapy, in Women With Recurrent Epithelial Ovarian, Fallopian Tube, or Primary Peritoneal Cancer [Phase 1, Phase 2]
This clinical trial update reports the completion of a Phase 1/2 study evaluating the safety of KAND567 in combination with carboplatin in w…
-
CLINICAL_TRIALS trial_result · 2025-05-31Clinical Trial Update: Ribociclib + PDR001 in Breast Cancer and Ovarian Cancer [Phase 1]
A Phase 1 trial evaluating ribociclib in combination with PDR001 for metastatic hormone-receptor-positive (HR+) breast cancer, HER2-negative…
-
CLINICAL_TRIALS research · 2025-05-20Clinical Trial Update: Phase I-II, FIH, TROP2 ADC, Advanced Unresectable/Metastatic Solid Tumors, Refractory to Standard Therapies (KL264-01) [Phase 1, Phase 2]
KL264-01, a Trop2-targeted antibody-drug conjugate, is being studied in a Phase 1/2 trial for advanced unresectable or metastatic solid tumo…
-
CLINICAL_TRIALS research · 2025-05-16Clinical Trial Update: EON: A Single-arm Phase II Study of Etigilimab (OMP-313M32) in Combination With Checkpoint Inhibition (Nivolumab) in Patients With Platinum-resistant, Recurrent Epithelial Ovarian Cancer [Phase 2]
Phase II single-arm study evaluating Etigilimab (OMP-313M32) with nivolumab in platinum-resistant, recurrent epithelial ovarian cancer; the …
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2025-04-15Clinical Trial Update: TH1902 in Patients With Advanced Solid Tumors [Phase 1]
This is a Phase 1 clinical trial update for TH1902 in patients with advanced solid tumors. The study is currently active/not recruiting and …
-
CLINICAL_TRIALS trial_result · 2025-03-26Clinical Trial Update: Study of the Effects of Pembrolizumab in Patients With Advanced Solid Tumors [Phase 2]
Phase 2 study evaluating pembrolizumab in patients with advanced solid tumors, including squamous cell carcinoma of the head and neck, tripl…
-
CLINICAL_TRIALS withdrawal · 2025-03-19Clinical Trial Update: A Post-marketing Surveillance to Assess the Safety and Effectiveness of Zirabev in Domestic Patients With Various Cancer
Pfizer's post-marketing surveillance study of Zirabev to assess safety and effectiveness in domestic cancer patients has been withdrawn.
-
CLINICAL_TRIALS trial_result · 2025-03-17Clinical Trial Update: RRx-001 in Lung Cancer, Ovarian Cancer and Neuroendocrine Tumors Prior to Re-administration of Platinum Based Doublet Regimens (QUADRUPLE THREAT) [Phase 2]
A Phase 2 trial (QUADRUPLE THREAT) evaluated RRx-001 in small cell lung cancer, non-small cell lung cancer, neuroendocrine tumors, and epith…
-
CLINICAL_TRIALS research · 2025-03-17Clinical Trial Update: Retrospective Evaluation of Minimally-Invasive Surgical Strategies in Ovarian Neoplasms (REMISSION Study)
The REMISSION study is a clinical trial evaluating minimally invasive surgical strategies for epithelial ovarian cancer to assess outcomes. …
-
CLINICAL_TRIALS trial_result · 2025-03-07Clinical Trial Update: Efficacy of Letrozole in Recurrent Ovarian Cancer [Phase 3]
Phase 3 trial evaluating letrozole for recurrent epithelial ovarian cancer has been terminated; the update does not include efficacy results…
-
CLINICAL_TRIALS research · 2025-03-03Clinical Trial Update: Regional Distribution Mapping of Lymph Node Metastasis in Epithelial Ovarian Cancer
This is a completed clinical trial update examining regional distribution of lymph node metastasis in epithelial ovarian cancer; results are…
-
CLINICAL_TRIALS research · 2025-02-27Clinical Trial Update: Tinzaparin And Biomarkers After Neoadjuvant Treatment of Ovarian Cancer [Phase 2]
A Phase 2 clinical trial is evaluating tinzaparin and biomarker analyses after neoadjuvant treatment in epithelial ovarian cancer; the study…
-
CLINICAL_TRIALS withdrawal · 2025-02-21Clinical Trial Update: QUILT-3.051: NANT Ovarian Cancer Vaccine: Combination Immunotherapy in Subjects With Epithelial Ovarian Cancer Who Have Progressed on or After Standard-of-care (SoC) Therapy [Phase 1, Phase 2]
The QUILT-3.051 trial evaluating the NANT Ovarian Cancer Vaccine in epithelial ovarian cancer has been withdrawn in subjects who progressed …
-
CLINICAL_TRIALS trial_result · 2025-02-20Clinical Trial Update: PARPi and Ovarian Cancer Survival
A not-yet-recruiting clinical trial is investigating a PARP inhibitor for epithelial ovarian cancer and related cancers of the fallopian tub…
-
CLINICAL_TRIALS research · 2025-02-10Clinical Trial Update: Study of Upfront Surgery Versus Neoadjuvant Chemotherapy in Patients With Advanced Ovarian Cancer (SUNNY) [Phase 3]
Phase 3 clinical trial SUNNY compares upfront surgery to neoadjuvant chemotherapy in advanced ovarian cancer. The study is currently active …
-
CLINICAL_TRIALS trial_result · 2025-01-27Clinical Trial Update: Letrozole for Estrogen/Progesterone Receptor Positive Low-grade Serous Epithelial Ovarian Cancer (LEPRE Trial) [Phase 3]
A Phase 3 trial (LEPRE) is evaluating letrozole for estrogen/progesterone receptor-positive low-grade serous epithelial ovarian cancer and i…
-
CLINICAL_TRIALS research · 2025-01-23Clinical Trial Update: Study of CBX-12 in Subjects With Advanced or Metastatic Refractory Solid Tumors [Phase 1, Phase 2]
Phase 1/2 study of CBX-12 in adults with advanced or metastatic refractory solid tumors. The trial includes multiple cancer types and is cur…
-
CLINICAL_TRIALS research · 2024-12-27Clinical Trial Update: EPITOME-1015-I: a Study to Investigate the Safety and Tolerability of MDG1015 in Patients with Epithelial Ovarian Cancer, Gastroesophageal Adenocarcinoma, Round Cell Liposarcoma And/or Synovial Sarcoma [Phase 1]
This is a Phase 1 study to evaluate the safety and tolerability of MDG1015 in patients with epithelial ovarian cancer, gastroesophageal junc…
-
CLINICAL_TRIALS research · 2024-12-16Clinical Trial Update: Prognostic and Diagnostic Added Value of Medical Imaging in Gynecological Cancer (PRODIGYN)
The PRODIGYN study is a prospective trial evaluating the added prognostic and diagnostic value of medical imaging in gynecologic cancers and…
-
CLINICAL_TRIALS trial_result · 2024-12-13Clinical Trial Update: Epacadostat Before Surgery in Treating Patients With Newly Diagnosed Stage III-IV Epithelial Ovarian, Fallopian Tube, or Primary Peritoneal Cancer [EARLY_Phase 1]
An early-phase study evaluating epacadostat given before surgery in newly diagnosed, advanced ovarian, fallopian tube, or primary peritoneal…
-
CLINICAL_TRIALS research · 2024-12-05Clinical Trial Update: T-regulatory Cell Depletion with E7777 Combined with Pembrolizumab in Recurrent or Metastatic Solid Tumors [Phase 1, Phase 2]
A Phase 1/2 clinical trial evaluating regulatory T-cell depletion with E7777 in combination with pembrolizumab for recurrent or metastatic e…
-
CLINICAL_TRIALS research · 2024-12-04Clinical Trial Update: Epithelial Ovarian Cancer- Staging and Response to Chemotherapy Evaluated by PET/CT
Clinical trial update from Turku University Hospital evaluating how PET/CT staging correlates with chemotherapy response in epithelial ovari…
-
CLINICAL_TRIALS research · 2024-11-21Clinical Trial Update: The Application of Sentinel Lymph Node Mapping Technique in the Surgery of Early Epithelial Ovarian Cancer [NA]
A clinical trial registered to evaluate sentinel lymph node mapping in the surgery of early epithelial ovarian cancer. The study is not yet …
-
CLINICAL_TRIALS research · 2024-11-15Clinical Trial Update: A Phase 1/2a Study of 23ME-00610 in Patients With Advanced Solid Malignancies [Phase 1, Phase 2]
Clinical trial registry entry for a Phase 1/2a study of 23ME-00610 in patients with advanced solid malignancies, including several gynecolog…